Table 1 Clinical and demographic characteristics of the study sample. *sd = Standard Deviation; EDSS = Expanded Disability Status Scale; METs = Moderate Efficacy Therapies; HETs = High Efficacy Therapies; W = Wtihout; RMS = Relapsing Multiple Sclerosis; SPMS = Secondary Progressive Multiple Sclerosis
Age, years, mean ± sd* | 47.28 ± 12.34 |
|---|---|
Gender, n (%) | |
Female | 132 (74.16) |
Education, n (%) | |
Elementary school | 2 (1.12) |
Middle school | 28 (15.73) |
High school | 84 (47.19) |
Three-year degree | 12 (6.74) |
Master’s degree | 52 (29.21) |
Body Mass Index (BMI), n (%) | |
Underweight | 11 (6.18) |
Healthy | 109 (61.24) |
Overweight | 47 (24.40) |
Obese | 11 (6.18) |
EDSS*, mean ± sd* | 3.07 ± 1.81 |
Duration of illness, mean ± sd* | 12.58 ± 9.50 |
Disease modyfing therapies (DTMs), n (%) | |
METs* | 78 (47.56) |
HETs* | 34 (20.73) |
W*_DMTs | 52 (31.71) |
Physiotherapy training during study, n (%) | |
No | 132 (74.14) |
Working status during study, n (%) | |
No | 62 (34.83) |
Clinical phenotypes, n (%) | |
RMS* | 147 (82.58) |
SPMS* | 31 (17.52) |